CTRI/2023/10/058896招募中Unknown
Impact of SGLT-2 Inhibitors on Renal Function Among the Patients Undergoing Percutaneous Coronary Interventions with Type 2 Diabetes and Coronary Artery Disease: A Cohort Study - nil
GSM Institute of Pharmaceutical Science0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age - >18 years
- •Medication duration 3months - 3years
- •T2DM with indication of PCI
- •Obstructive coronary artery disease, characterized by a =50% narrowing in a major epicardial vessel, and who also have a clinical indication for undergoing PCI.
- •Willing to provide consent to participate in the study
- •eGFR range 50-90 ml/min/1.73m2
排除标准
- •Auto immune disease
- •Chronic use of anti-inflammatory medications.
- •Severe anemia
- •Cardiogenic shock
- •Use of nephrotoxic drugs
- •History of CIN
- •Use of contrast media less than 7 days
研究者
相似试验
Unknown
4 期
Effect of SGLT2 inhibitor on Renal Function and Urinary [TIMP-2] x [IGFBP7] in Patients Hospitalized for Acute Heart Failure; A Randomized Controlled TrailAcute kidney injury and urinary [TIMP-2] x [IGFBP7] in patient hospitalized for acute heart failureAcute kidney injury, urinary [TIMP-2] x [IGFBP7], nephrocheck, acute heart failure, acute decompensated heart failure, SGLT2 inhibitor, renal function, biomarkerTCTR20221003002/A66
进行中（未招募）
1 期
The RECEDE-CHF TrialType 2 diabetes and heart failureMedDRA version: 20.0Level: LLTClassification code 10008908Term: Chronic heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10010684Term: Congestive heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849MedDRA version: 20.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2016-003968-39-GBniversity of Dundee/NHS Tayside23
招募中
不适用
Investigation of renal protective effects of SGLT2 inhibitor by using renal doppler ultrasonographyJPRN-UMIN000028438Ogawa Red Cross Hospital60
已完成
3 期
Evaluation Renoprotective Effect SGLT2 inhibitors on Prognosis of Transplant Kidney PatientsCondition 1: Diabetes mellitus type 2. Condition 2: Transplant Kidney.Type 2 diabetes mellitus with kidney complicationsKidney transplant statusE11.2Z94.0IRCT20220708055414N1Orchidpharmed30
已完成
不适用
ong-term renoprotective effect of SGLT2 inhibitorstype 2 diabetes melllitusJPRN-UMIN000034387ephrology Division, JA Toride Medical Center60